Cencora, Inc. (COR) Institutional Ownership & Insider Trading

1,344 institutions reported holding Cencora, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 17 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CORCencora, Inc.Follow COR — free

Medical Distribution · Healthcare

—

Price chart with a free account

Market cap: 63.2B
P/E TTM: 24.6
Dividend yield: 0.7%
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,344 institutions held 96.2% of the shares. Across filers that reported both quarters, shares held changed -0.9%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,344	184	-0.9%	374	64	540	155
Mar 26	1,413	181	-1.8%	436	88	469	109
Dec 25	1,432	186	+0.9%	402	116	453	69
Sep 25	1,326	183	+4.1%	448	94	371	70
Jun 25	1,321	184	-1.7%	429	123	406	63
Mar 25	1,257	184	-3.5%	360	130	414	78
Dec 24	1,192	194	-2.1%	392	74	326	63
Sep 24	1,131	191	-4.2%	395	88	313	69

Cencora, Inc. — questions

Who owns Cencora, Inc. stock?: 1,344 institutions reported Cencora, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (9.5%), VANGUARD CAPITAL MANAGEMENT LLC (6.5%), VANGUARD PORTFOLIO MANAGEMENT LLC (5.0%).
Are Cencora, Inc. insiders buying or selling?: 17 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Cencora, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.